STERIS plc

STE · NYSE · USD

Financials

Annual

StatisticsIncome statementBalance sheetCash flowDividendsSegments

Valuation and market statistics · USD millions unless noted · ratios on the twelve months ending at each period

Line item	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008	FY2007	FY2006	FY2005	FY2004	FY2003	FY2002	FY2001	FY2000	FY1999	FY1998	FY1997	FY1996	FY1995	FY1994	FY1993	FY1992	FY1991
Valuation
Market cap	$21,687	$22,269	$22,215	$18,991	$24,208	$19,052	$14,000	$12,806	$9,338	$6,948	$7,107	$7,029	$2,816	$2,400	$1,846	$2,048	$1,980	$1,368	$1,696	$1,732	$1,684	$1,751	$1,788	$1,823	$1,459	$928	$672	$1,823	$1,858	$829	$534	$350	$204	$139	$41	$27
Enterprise value	$23,348	$24,312	$25,405	$22,041	$27,152	$20,645	$14,978	$13,777	$10,464	$8,154	$8,441	$7,484	$3,159	$2,752	$1,906	$2,067	$1,976	$1,425	$1,824	$1,781	$1,728	$1,834	$1,821	$1,859	$1,564	$1,111	$907	$2,023	$1,995	$844	$496	$349	$202	$119	$40	$28
P/E (TTM) at period end	27.72×	36.23×	58.74×	177.44×	99.26×	47.94×	34.34×	42.16×	32.10×	63.18×	64.16×	52.04×	21.75×	15.00×	13.56×	39.96×	15.41×	12.36×	21.99×	21.08×	23.96×	20.36×	18.97×	22.95×	31.58×	705.00×	64.06×	21.48×	28.36×	–	13.09×	–	32.42×	55.44×	–	–
P/S (TTM) at period end	3.65×	4.08×	4.32×	4.19×	5.73×	6.13×	4.62×	4.60×	3.56×	2.66×	3.17×	3.80×	1.74×	1.60×	1.31×	1.70×	1.57×	1.05×	1.34×	1.45×	1.45×	1.62×	1.73×	1.88×	1.68×	1.16×	0.88×	2.29×	2.58×	1.41×	1.00×	0.64×	4.46×	5.19×	3.19×	3.12×
P/B at period end	3.02×	3.37×	3.53×	3.12×	3.71×	4.91×	4.11×	4.03×	2.91×	2.48×	2.35×	6.56×	2.71×	2.54×	2.25×	2.60×	2.63×	1.91×	2.40×	2.24×	2.30×	2.32×	2.63×	3.20×	3.00×	2.19×	1.60×	4.18×	5.17×	2.81×	1.76×	7.86×	5.80×	5.15×	7.77×	18.31×
EV / EBITDA (TTM)	14.70×	18.11×	18.13×	16.40×	26.34×	26.90×	20.40×	21.63×	18.10×	19.68×	23.67×	23.48×	11.18×	8.82×	6.68×	14.80×	7.60×	6.08×	9.79×	9.00×	10.31×	9.52×	10.26×	10.79×	12.26×	15.70×	13.07×	11.92×	14.58×	8.36×	5.54×	4.14×	23.17×	43.96×	–	69.66×
EV / Sales (TTM)	3.93×	4.45×	4.94×	4.86×	6.43×	6.64×	4.94×	4.95×	3.99×	3.12×	3.77×	4.04×	1.95×	1.83×	1.35×	1.71×	1.57×	1.10×	1.44×	1.49×	1.49×	1.70×	1.76×	1.91×	1.80×	1.39×	1.19×	2.54×	2.77×	1.44×	0.93×	0.64×	4.40×	4.45×	3.12×	3.17×
Returns
Return on equity	10.9%	9.3%	6.0%	1.8%	3.7%	10.2%	12.0%	9.6%	9.1%	3.9%	3.7%	12.6%	12.5%	16.9%	16.6%	6.5%	17.0%	15.4%	10.9%	10.6%	9.6%	11.4%	13.8%	13.9%	9.5%	0.3%	2.5%	19.5%	18.2%	(10.4%)	13.4%	(84.5%)	17.9%	9.3%	–	–
Return on invested capital	9.3%	7.7%	6.9%	7.1%	3.9%	7.7%	10.0%	8.2%	7.6%	3.4%	3.2%	9.6%	10.3%	13.2%	16.3%	7.3%	18.2%	15.1%	9.5%	10.2%	8.2%	10.2%	12.3%	13.3%	8.6%	0.9%	2.8%	14.3%	13.8%	27.2%	15.3%	77.5%	14.8%	31.6%	–	10.5%
Dividend yield	1.1%	1.0%	0.9%	1.0%	0.7%	0.7%	0.9%	0.9%	1.1%	1.3%	0.9%	0.8%	1.7%	1.8%	2.1%	1.6%	7.3%	1.3%	0.9%	0.7%	0.6%	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Financial health
Current ratio	2.09×	1.96×	3.08×	2.33×	2.04×	2.10×	2.43×	2.27×	2.48×	2.67×	2.43×	2.54×	2.65×	2.81×	2.34×	2.05×	2.92×	2.74×	2.23×	2.23×	1.97×	1.89×	2.43×	1.86×	1.86×	2.21×	2.50×	2.50×	2.03×	1.89×	2.71×	4.11×	5.21×	7.20×	2.41×	1.44×
Debt / equity	0.27×	0.31×	0.51×	0.51×	0.47×	0.43×	0.34×	0.37×	0.41×	0.53×	0.52×	0.58×	0.48×	0.52×	0.26×	0.27×	0.28×	0.29×	0.25×	0.13×	0.16×	0.14×	0.17×	0.11×	0.24×	0.49×	0.64×	0.51×	0.43×	0.12×	0.34×	–	–	–	–	0.47×
Effective tax rate	25.0%	23.2%	21.3%	18.2%	22.4%	23.3%	18.2%	17.4%	17.8%	40.1%	35.1%	35.3%	31.3%	29.6%	35.5%	30.6%	33.0%	33.5%	35.6%	39.0%	41.8%	39.5%	31.8%	36.0%	37.0%	77.1%	38.0%	33.3%	39.0%	(524.5%)	41.7%	49.4%	40.0%	3.8%	–	–
Share count
Diluted shares outstanding	99	99	99	100	98	86	86	85	86	86	71	60	60	59	59	60	59	59	64	66	69	70	71	71	71	66	70	71	69	68	36	35	35	34	20	13

StatisticsIncome statementBalance sheetCash flowDividendsSegments

Income statement · USD millions

Line item	TTM	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008	FY2007	FY2006	FY2005	FY2004	FY2003	FY2002	FY2001	FY2000	FY1999	FY1998	FY1997	FY1996	FY1995	FY1994	FY1993	FY1992	FY1991
Revenue and gross profit
Revenue	$6,038	$5,936	$5,460	$5,139	$4,536	$4,223	$3,108	$3,031	$2,782	$2,620	$2,613	$2,239	$1,850	$1,622	$1,502	$1,407	$1,207	$1,258	$1,299	$1,265	$1,197	$1,160	$1,082	$1,032	$972	$867	$800	$761	$798	$720	$588	$535	$546	$46	$27	$13	$9
Cost of revenue	($3,355)	($3,309)	($3,057)	($2,920)	($2,556)	($2,340)	($1,764)	($1,711)	($1,607)	($1,527)	($1,587)	($1,343)	($1,076)	($973)	($881)	($838)	($761)	($719)	($772)	($741)	($693)	($676)	($620)	($588)	($563)	($511)	($426)	($406)	($396)	($371)	($340)	($312)	($322)	($17)	($11)	($6)	($3)
Gross profit	$2,683	$2,626	$2,403	$2,218	$1,981	$1,883	$1,343	$1,320	$1,175	$1,093	$1,026	$895	$774	$650	$621	$568	$446	$539	$527	$524	$505	$484	$462	$444	$409	$355	$375	$355	$402	$349	$248	$222	$223	$29	$16	$7	$5
Operating expenses
Research and development	($115)	($113)	($108)	($104)	($98)	($87)	($66)	($66)	($63)	($61)	($59)	($57)	($54)	($49)	($41)	($36)	($34)	($34)	($33)	($37)	($34)	($34)	($32)	($28)	($26)	($22)	($24)	($24)	($25)	($24)	($22)	($18)	($17)	–	–	–	–
Selling, general and administrative	($1,424)	($1,408)	($1,334)	($1,252)	($1,091)	($1,318)	($731)	($717)	($670)	($632)	($682)	($627)	($493)	($381)	($338)	($310)	($325)	($297)	($315)	($348)	($327)	($316)	($289)	($288)	($258)	($253)	($280)	($262)	($207)	($188)	($126)	($115)	($122)	($20)	($13)	($7)	($5)
Total operating expenses	($1,541)	($1,525)	($1,536)	($1,382)	($1,190)	($1,405)	($795)	($783)	($764)	($693)	($800)	($683)	($547)	($443)	($378)	($346)	($361)	($335)	($351)	($400)	($367)	($374)	($321)	($315)	($283)	($275)	($350)	($325)	($266)	($236)	($164)	($153)	($158)	($21)	($14)	–	($5)
Total costs and expenses	($4,896)	($4,834)	($4,593)	($4,303)	($3,745)	($3,746)	($2,559)	($2,494)	($2,371)	($2,220)	($2,387)	($2,026)	($1,623)	($1,415)	($1,259)	($1,184)	($1,122)	($1,054)	($1,123)	($1,142)	($1,060)	($1,051)	($940)	($903)	($846)	($786)	($776)	($731)	($661)	($607)	($504)	($465)	($480)	($38)	($24)	–	($9)
Operating income	$1,142	$1,102	$867	$836	$791	$478	$548	$537	$411	$400	$226	$213	$227	$207	$243	$222	$85	$204	$175	$124	$138	$110	$141	$129	$126	$81	$24	$30	$136	$113	$84	$70	$66	$8	$2	–	$0
Earnings
EBITDA	$1,632	$1,588	$1,343	$1,401	$1,344	$1,031	$768	$734	$637	$578	$414	$357	$319	$282	$312	$285	$140	$260	$234	$186	$198	$168	$193	$177	$172	$127	$71	$69	$170	$137	$101	$90	$84	$9	$3	–	$0
Interest income	–	$10	$8	$11	–	$6	$6	$2	$3	$6	$3	$2	$1	$0	–	$1	$1	$1	$2	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Interest expense	($61)	($61)	($86)	($144)	($108)	($89)	($37)	($40)	($45)	($51)	($45)	($43)	($19)	($19)	($16)	($12)	($12)	($13)	($11)	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Pre-tax income	$1,089	$1,047	$796	$703	$680	$367	$518	$499	$369	$355	$185	$172	$209	$188	$227	$211	$74	$192	$166	$120	$133	$108	$138	$126	$124	$73	$6	$17	$127	$107	($5)	$70	$31	$8	$3	–	–
Income tax expense	($281)	($262)	($185)	($150)	($124)	($82)	($121)	($91)	($64)	($63)	($74)	($60)	($74)	($59)	($67)	($75)	($23)	($63)	($56)	($43)	($52)	($45)	($55)	($40)	($45)	($27)	($4)	($6)	($42)	($42)	($26)	($29)	($15)	($3)	($0)	–	–
Net income	$805	$782	$615	$378	$107	$244	$397	$408	$304	$291	$110	$111	$135	$129	$160	$136	$51	$128	$111	$77	$82	$70	$86	$94	$79	$46	$1	$10	$85	$65	($31)	$41	($38)	$6	$2	–	–
Per share
Diluted EPS (GAAP)	$8.18	$7.93	$6.20	$3.81	$1.07	$2.48	$4.63	$4.76	$3.55	$3.39	$1.28	$1.56	$2.25	$2.17	$2.72	$2.31	$0.85	$2.16	$1.86	$1.20	$1.25	$1.02	$1.23	$1.33	$1.12	$0.65	$0.02	$0.15	$1.20	$0.95	($0.45)	$0.30	($0.14)	$0.075	$0.02	($0.0125)	($0.015)
Basic EPS (GAAP)	$8.20	$7.97	$6.24	$3.83	$1.07	$2.50	$4.66	$4.81	$3.59	$3.42	$1.29	$1.57	$2.27	$2.20	$2.74	$2.33	$0.86	$2.18	$1.88	$1.22	$1.26	$1.03	$1.24	$1.36	$1.14	$0.67	$0.02	$0.16	$1.24	$0.95	($0.45)	$0.30	($0.14)	$0.08	$0.02	($0.0125)	($0.015)
Basic shares outstanding	98	98	99	99	100	98	85	85	85	85	85	71	59	59	58	58	59	59	59	63	65	68	69	69	70	69	66	66	68	69	68	36	35	35	34	20	13
Margins
Gross margin	44.4%	44.2%	44.0%	43.2%	43.7%	44.6%	43.2%	43.6%	42.2%	41.7%	39.3%	40.0%	41.8%	40.0%	41.4%	40.4%	37.0%	42.9%	40.6%	41.4%	42.2%	41.7%	42.7%	43.0%	42.1%	41.0%	46.8%	46.7%	50.4%	48.5%	42.3%	41.6%	40.9%	62.4%	59.9%	56.6%	61.4%
Operating margin	18.9%	18.6%	15.9%	16.3%	17.4%	11.3%	17.6%	17.7%	14.8%	15.3%	8.7%	9.5%	12.3%	12.7%	16.2%	15.8%	7.1%	16.2%	13.5%	9.8%	11.5%	9.5%	13.1%	12.5%	12.9%	9.3%	3.0%	3.9%	17.1%	15.7%	14.4%	13.1%	12.1%	17.5%	8.6%	–	2.3%
Net margin	13.3%	13.2%	11.3%	7.4%	2.4%	5.8%	12.8%	13.5%	10.9%	11.1%	4.2%	4.9%	7.3%	8.0%	10.7%	9.7%	4.2%	10.2%	8.5%	6.1%	6.9%	6.1%	7.9%	9.1%	8.2%	5.3%	0.2%	1.4%	10.6%	9.1%	(5.2%)	7.6%	(6.9%)	13.8%	9.4%	–	–

Analyst consensus

Buy14 analysts

Bearish · 0 · Hold · 2 · Bullish · 12

Earnings history

	EPS	Estimate
Q2 2025	$2.14	$2.12	Beat
Q3 2025	$2.32	$2.33	Miss
Q4 2025	$2.74	$2.60	Beat
Q1 2026	$2.34	$2.26	Beat
Q2 2026	$2.47	$2.35	Beat
Q3 2026	$2.53	$2.53	Match
Q4 2026	$2.83	$2.85	Miss
Q1 2027	$2.59	$2.49	Beat

Peers

Company overview

IPO dateJun 1, 1992

CEODaniel A. Carestio

Employees17,937

SectorHealthcare

IndustryMedical - Specialties

CountryUS

ExchangeNew York Stock Exchange

Websitewww.steris.com

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It also provides services such as equipment maintenance, instrument repair, and contract sterilization for medical device and pharmaceutical manufacturers.

Athenic provides research and information tools for educational purposes only and is not a registered investment adviser or broker-dealer. Nothing on this page is investment advice or a recommendation to buy or sell any security. Market data may be delayed. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal.